Evaluation of Image-Defined Risk Factor (IDRF) Assessment in Patients With Intermediate-risk Neuroblastoma: A Report From the Children's Oncology Group Study ANBL0531

In brief

This study evaluates how accurately institutions assess image-defined risk factors (IDRFs) in intermediate-risk neuroblastoma patients compared to standardized central review. The research examines the reliability of IDRF-based staging criteria used in the International Neuroblastoma Risk Group classification system through prospective analysis of COG study ANBL0531 data.

• INRG staging uses image-defined risk factors (IDRFs) to assess locoregional neuroblastoma extent before treatment.
• COG study ANBL0531 compared institutional IDRF assessments to standardized central review for quality assurance.
• Prospective validation of IDRF criteria helps standardize risk stratification in intermediate-risk neuroblastoma patients.

Written by the GCMD Library team from the article.